Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Sebastian J. Schober, Irene von Luettichau, Angela Wawer, Maximilian Steinhauser, Christoph Salat, Wolfgang Schwinger, Marek Ussowicz, Petar Antunovic, Luca Castagna, Hans-Jochem Kolb, Stefan EG Burdach, Uwe Thiel
Published Apr 27, 2018 · Vol. 9, No. 32 · pp. 22741-22748
Ali Hosni, Kathy Han, Lisa W. Le, Jolie Ringash, James Brierley, Rebecca Wong, Robert Dinniwell, Anthony Brade, Laura A. Dawson, Bernard J. Cummings, Monika K. Krzyzanowska, Eric X. Chen, David Hedley, Jennifer Knox, Alexandra M. Easson, Patricia Lindsay, Tim Craig, John Kim
Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20439-20450
Antonino Tuttolomondo, Claudia Colomba, Danilo Di Bona, Alessandra Casuccio, Domenico Di Raimondo, Giuseppe Clemente, Valentina Arnao, Rosaria Pecoraro, Paolo Ragonese, Anna Aiello, Giulia Accardi, Rosario Maugeri, Carlo Maida, Irene Simonetta, Vittoriano Della Corte, Domenico Gerardo Iacopino, Calogero Caruso, Antonio Cascio, Antonio Pinto, on behalf of KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group
Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17523-17532
